Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00057382
Status:
TERMINATED
Last Update Posted:
2005-06-24
First Post:
2003-03-31
Brief Title:
T138067 Versus Doxorubicin in Chemotherapy-Naive Unresectable Hepatocellular Carcinoma Patients
Sponsor:
Tularik
Organization:
Tularik
Organization Data
Organization:
Tularik
Class:
INDUSTRY
Study ID:
T-067-010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tularik
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None